November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreDecember 02, 2025
According to market projections, the 503A U.S. compounding pharmacies sector is expected to grow from USD 4.74 billion in 2025 to USD 8.58 billion by 2035, reflecting a CAGR of 6.11%. 503A U.S. compounding pharmacies create customized medications tailored to individual patient needs based on a prescription. They follow strict state and federal regu...
December 02, 2025
Market insights predict the global biotechnology industry will increase to USD 5666.02 billion by 2035 rapidly fueled by breakthroughs in healthcare, agriculture, and industry. With a 12.5% CAGR over the next decade, innovations in gene therapy, CRISPR, AI-driven drug discovery, and mRNA tech are leading the way, especially in cancer and rare disea...
December 01, 2025
Projections indicate that, the global hematuria treatment market will increase from USD 1.13 billion in 2025 to USD 1.55 billion by 2035, experiencing a CAGR of 3.15% over the next 10 years. The rising prevalence of urinary tract disorders and growing research and development activities bolster market growth. The burgeoning healthcare infrastructur...
December 01, 2025
Based on market forecasts, the pemphigus vulgaris sector will expand from USD 530.43 million in 2025 to USD 1171.93 million by 2035, experiencing a CAGR of 8.25%. The pemphigus vulgaris market is growing due to increasing clinical trials aimed at developing novel therapeutics. North America is leading the market because of the strong presence of th...
December 01, 2025
Market insights predict the global orthopedic braces & supports industry will increase from USD 4.09 billion in 2025 to USD 7.65 billion by 2035, achieving a CAGR of 6.46%. The orthopedic braces & supports market is growing because it is a type of medical device which are used for injury prevention, rehabilitation and post-surgical recovery...
December 01, 2025
According to market projections, the tangential flow filtration sector is expected to grow from USD 2.35 billion in 2025 to USD 7.59 billion by 2035, reflecting a CAGR of 12.44%. Over the globe, the growth of the market is impacted by increasing demand for biopharmaceuticals and biologics, technological advancements for membranes, and the need for ...
December 01, 2025
Market insights predict, the U.S. biopharmaceutical third-party logistics industry is expected to grow from USD 61.08 billion in 2025 to USD 127.06 billion by 2035, driven by a CAGR of 7.6%. Rising complexities and volume of biopharmaceutical products like monoclonal antibodies and gene therapies, and also, branded drugs, are driving the growth of ...
December 01, 2025
Based on market forecasts, the global cell and gene therapy third-party logistics market, projected at USD 1.81 billion in 2025, is expected to reach USD 16.95 billion by 2035, growing at a CAGR of 25.05% over the forecast period. The cell and gene therapy third-party logistics market is growing significantly due to the rise in the usage of persona...
November 28, 2025
Projections indicate that, the global oral mucositis market will increase from USD 1.64 billion in 2025 to USD 3.35 billion by 2035, experiencing a CAGR of 7.38% over the next 10 years. Sophisticated imaging and diagnostic technologies are driving the oral mucositis market. North America is led by key market players and an advanced healthcare infra...
November 28, 2025
Projections indicate that, hyperkalemia drugs industry is projected to rise from USD 1.42 billion in 2025 to USD 5.20 billion by 2035, reflecting a CAGR of 13.84% over the next decade. The market is growing due to the rising prevalence of chronic kidney disease, heart failure, and the use of RAAS inhibitors, increasing the need for effective potass...